Skip to content

Effects of Arnica ointment and cold on pain and bruising caused by enoxaparin injection

Effects of Arnica ointment and cold compress on pain and bruising caused by enoxaparin injection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017020832465N1
Enrollment
90
Registered
2017-03-17
Start date
2016-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Injection pain. Condition 2: Bruising assossiated with injection. Acute pain Superficial injury of unspecified body region

Interventions

Intervention 1: In this method 1 gr Arnica ointment is placed on the injection site with holder dressing 60 minute before the injection and dressing is removed after the one hour, then area is cleaned
Prevention
In this method 1 gr Arnica ointment is placed on the injection site with holder dressing 60 minute before the injection and dressing is removed after the one hour, then area is cleaned and injection i
In this method, a piece of ice the size of 4*2*2 Cm is placed inside the latex gloves and two layers of gas is placed on the injection site 5 minute before the injection, Then piece of ice is used at
Injection Enoxaparin without interference

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Physician's order to receive subcutaneous enoxaparin, Agreed to participate in the study and complete and sign the consent form, orientation to person/place/time/situation, no prescription of narcotic analgesics 4 hours before injection, Exclusion criteria: patient Not wanting to continue studying, allergy to Arnica ointment, loss of consciousness or died patient during the study, coagulation disorders, Presence of scar tissue, any skin lesion or unilateral senso neural obvious defects, receiving other anticoagulants such as warfarin and heparin

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Measuring pain severity. Timepoint: Immediately after injection. Method of measurement: using visual analog scale.

Secondary

MeasureTime frame
Measuring of bruise. Timepoint: 24 - 48 and 72 hours after injection. Method of measurement: using ruler.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEshrat Jameiati

Gonabad University of Medical Sciences

E.jameiati@gmu.ac.ir+98 51 5722 9015

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026